Cargando…
Pharmacokinetic studies for proving bioequivalence of orally inhaled drug products—critical issues and concepts
Autores principales: | Thakkar, Karan, Mhatre, Suyog, Jadhav, Manish, Goswami, Sailendra, Shah, Rajen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452802/ https://www.ncbi.nlm.nih.gov/pubmed/26089798 http://dx.doi.org/10.3389/fphar.2015.00117 |
Ejemplares similares
-
Pharmacokinetic Bioequivalence of Two Inhaled Tiotropium Bromide Formulations in Healthy Volunteers
por: Algorta, Jaime, et al.
Publicado: (2016) -
Pharmacokinetics and bioequivalence of sunitinib and Sutent(®) in Chinese healthy subjects: an open-label, randomized, crossover study
por: Wang, Yanli, et al.
Publicado: (2023) -
The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs
por: Thakkar, Karan B., et al.
Publicado: (2013) -
Current Bioequivalence Study Designs in South Korea: A Comprehensive Analysis of Bioequivalence Study Reports Between 2013 and 2019
por: Huh, Ki Young, et al.
Publicado: (2021) -
Pharmacokinetics and bioequivalence study of esomeprazole magnesium enteric-coated tablets 20 mg in healthy Chinese subjects under fasting and fed conditions
por: Ding, Ying, et al.
Publicado: (2023)